Mofast has sold 612.5 million shares in the real estate company Episurf Medical in two transactions for a total of SEK 40 million. The average price was approximately 6.5 öre per share.At the same time, Mofast intends to convert a convertible worth SEK 87.5 million at a price of 5.5 öre per share, corresponding to approximately 1.6 billion new shares.Following the conversion, Mofast is expected to own approximately 2.7 billion shares in Episurf, corresponding to around 16.5 percent based on the current number of shares.Mofast also has an additional convertible worth approximately SEK 82 million with a conversion price of 5.5 öre per share.- We have divested part of our holding in Episurf and have thereby strengthened our cash position by SEK 40 million. The sale was primarily carried out to enable us to convert one of our convertibles into shares without at the same time becoming too large an owner. At the same time, we remain one of the largest owners and believe in Episurf in the long term, comments Eric Fischbein, CEO of Mofast.